Episode 17: Appen’s acquisition, Advance NanoTek, Clinuval Pharmaceuticals and more!

This week, we dissect Appen’s latest acquisition and touch on the ethics of AI. We look to why shares in Envirosuite have surged higher, and ask whether the phenomenal gains from Clinuval Pharmaceuticals and Advance NanoTek can continue. Plus Matt updates us on his recent meeting with the PushPay team. Continue Reading